Richard Markham

Richard Markham

Keine laufenden Positionen mehr
75 Jahre
Health Technology
Finance
Consumer Services

Profil

Richard J.
Markham
formerly worked at Aventis Pharma AG, as Chief Executive Officer from 1999 to 2002, Hoechst Marion Roussel, Inc., as Chief Executive Officer, Acura Pharmaceuticals, Inc., as Non-Executive Chairman from 2006 to 2013, Aventis SA, as Vice Chairman & Chief Operating Officer in 2004, Vaxart, Inc., as Chairman, Medpace Research, Inc., as Chairman from 2007 to 2017, Cervelo Pharmaceuticals Ltd., as Chairman, Vaxart, Inc., as Chairman from 2009 to 2019, Sanofi Pasteur, Inc., as Director, CoLucid Pharmaceuticals, Inc., as Independent Director from 2008 to 2015, Marion Merrell Dow, Inc., as President, Chief Operating Officer & Director, Anacor Pharmaceuticals LLC, as Independent Director from 2011 to 2012, Pharmaceutical Research & Manufacturers Association, as Director, Merck & Co., Inc., as President & Chief Operating Officer from 1973 to 1993, Care Capital LLC, as Partner, and HealthCare Institute of New Jersey, as Trustee.
Dr. Markham received his undergraduate degree from Purdue University.

Ehemalige bekannte Positionen von Richard Markham

UnternehmenPositionEnde
Private Equity Investor 08.05.2022
VAXART, INC. Vorsitzender 30.11.2019
NEPHROGENEX INC Vorsitzender 28.02.2017
COLUCID PHARMACEUTICALS INC Direktor/Vorstandsmitglied 27.10.2015
ACURA PHARMACEUTICALS, INC. Vorsitzender 11.03.2013
Sehen Sie sich die Erfahrung von Richard Markham im Detail an

Ausbildung von Richard Markham

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

62

Beziehungen ersten Grades

17

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen17

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Consumer Services

Distribution Services

Health Technology

Pharmaceutical Research & Manufacturers Association

Aventis Pharma AG

Health Technology

Health Technology

Health Technology

  1. Börse
  2. Insiders
  3. Richard Markham